Gemcitabine HCL Injections

Gemcitabine HCL Injections Specification

Indication
Anticancer; used in the treatment of pancreatic, lung, breast, and ovarian cancers

Salt Composition
Gemcitabine Hydrochloride

Dosage Form
Injection

Origin
Pharmaceutical

Ingredients
Gemcitabine Hydrochloride, Excipients, Sterile Water for Injection

Application
Hospital, Clinic, Oncology

Physical Color/Texture
Colorless to pale yellow clear solution

Fermentation Smell
Odorless

Storage Instructions
Store below 25C, Protect from light, Do not freeze

Shelf Life
24 Months

Strength
200 mg/vial or 1 g/vial (as available)

Brand Name
Varies depending on manufacturer

Prescription
Prescription only medication

Packaging Size
Single vial pack

Route of Administration
Intravenous (IV) use only

Compatibility
Compatible with 0.9% Sodium Chloride Injection

Reconstitution
Reconstitute with sterile water for injection

Container Type
Glass vial

About Gemcitabine HCL Injections

Gemcitabine HCL:-

Gemcitabine is an anti-cancer chemotherapy drug and is classified as an antimetabolite. Gemcitabine is used to treat pancreas cancer, non-small cell lung cancer, bladder cancer, soft-tissue sarcoma, and metastatic breast cancer.

GEMZAR is approved by the FDA in combination with carboplatin (another type of chemotherapy) for the patient with advanced ovarian cancer that has returned at least 6 months after the patient had finished platinum-based therapy.
GEMZAR is approved by the FDA in combination with cisplatin (another type of chemotherapy) for the first-line treatment of patients (for whom surgery is not possible) with locally advanced (stage IIIA or stage IIIB) or metastatic (stage IV or cancer that has spread) non-small cell lung cancer.
GEMZAR is approved by the FDA in combination with paclitaxel for the first-line treatment of patients with metastatic breast cancer after they have received another type of chemotherapy called an anthracycline, unless their medical condition did not allow them to receive an anthracycline.
GEMZAR is approved by the FDA as a single agent (given alone) as the first-line treatment for patients with locally advanced (stage II or stage III when surgery is not an option) or metastatic (stage IV) adenocarcinoma of the pancreas. GEMZAR is also indicated for patients previously treated with 5-FU (another type of chemotherapy).

The most common side effects are low blood cell counts (red blood cells, white blood cells, and platelets); fever; infection; hair loss; tiredness; nausea; vomiting; constipation; diarrhea; rash; shortness of breath; muscle aches; blood in urine; hearing changes and numbness or tingling in your toes or fingers. Lab work may identify additional side effects.

Precise Dosing for Targeted Therapy

Gemcitabine HCL Injection is available in flexible strengths of 200 mg or 1 g per vial, accommodating individualized patient dosing regimens. Its targeted action against cancer cells makes it a preferred choice for oncologists treating multiple cancer types, ensuring effective therapy with each administration.

Safety and Compatibility

This medication must only be administered intravenously after proper reconstitution with sterile water for injection. It is compatible with 0.9% Sodium Chloride Injection, ensuring safe dilution. The glass vial packaging maintains product stability and sterility, contributing to reliable storage and transport.

Application in Hospitals and Oncology Clinics

Gemcitabine HCL Injection is widely used in oncology settings throughout hospitals and clinics for effective cancer management. Its prescription-only status ensures controlled use under the supervision of healthcare professionals, providing patients with tailored and closely monitored treatment regimens.

FAQs of Gemcitabine HCL Injections:

Q: How is Gemcitabine HCL Injection prepared and administered?

A: Gemcitabine HCL Injection must be reconstituted with sterile water for injection before use. After reconstitution, the solution is administered intravenously (IV) as directed by a healthcare professional in a hospital or oncology clinic.

Q: What cancers are treated with Gemcitabine HCL Injection?

A: This medication is indicated in the treatment of several cancers, including pancreatic, lung, breast, and ovarian cancer. Its use is determined by oncologists based on the specific patients condition and medical history.

Q: What are the main storage requirements for Gemcitabine HCL Injection?

A: The injection should be stored below 25C, protected from light, and should not be frozen. Always keep the vials in their original packaging until ready to use to ensure stability and sterility.

Q: When should Gemcitabine HCL Injection not be used?

A: Gemcitabine HCL Injection should not be used without a valid prescription or the supervision of a healthcare professional. Always inform your provider of allergies, medical history, or liver and kidney concerns before starting therapy.

Q: Where can Gemcitabine HCL Injection be purchased?

A: This product is supplied to hospitals, clinics, and licensed oncology centers by authorized dealers, distributors, exporters, suppliers, traders, and wholesalers in India. It is not available for retail purchase and requires a prescription.

Q: What are the benefits of using Gemcitabine HCL Injection in cancer treatment?

A: Gemcitabine HCL Injection is effective in slowing or stopping the growth of cancer cells, providing significant therapeutic benefits in various cancers. It is recognized for its targeted effect and adaptability across different oncologic conditions.

Get Latest Price